Non-Executive Director Kim Dong-geon Acquires 8,250 Additional Shares via Stock Purchase Rights (0.11% to 0.18%)
-
Non-executive director Kim Dong-geon exercised stock purchase rights on May 20, 2026, acquiring an additional 8,250 common shares
-
Acquisition prices were 1,500 won, 6,160 won, and 7,300 won per share, executed in three separate transactions
-
Shareholding increased from 15,000 shares (0.11%) to 23,250 shares (0.18%)
-
Acquired shares are subject to a mandatory one-year lock-up from listing date
KOSDAQ Filing Information
-
Filing: Report on Ownership of Specific Securities by Executives and Major Shareholders
-
Company: Kanaph Therapeutics (0082N0)
-
Submission: Kim Dong-geon
-
Receipt: 05-22-2026